Roche's Cerebrospinal Fluid Assays Approved in Canada for Alzheimer's Diagnosis

Roche Diagnostics Corporation has gained approval from Health Canada for its Cerebrospinal Fluid (CSF) assays to measure three biomarkers in adults aged 55 and over, allowing physicians to diagnose Alzheimer's disease. The Elecsys® beta-Amyloid, Phospho-Tau(181P), and Total-Tau CSF tests can be carried out on automated immunoassay analyzers available across the country. These biomarkers help tra..